Evidence map›Paper›PMID 38482517›Full record

ArticleInternational journal of MS care

Multiple Sclerosis, Fatigue, Expanded Disability Status Scale: A Cross-Sectional Exploration of Sleep Efficiency and Quantitative Sleep Parameters.

Munther Queisi, Hrayr Attarian, Veronica P Cipriani, Saria Azzi, Olivia Kaczmarek, Barbara Bumstead, Marijean Buhse, Myassar Zarif, Daniel Golan, Jeffrey Wilken and 2 more

Abstract read
In one paragraph

Article in International journal of MS care. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Nabiximols improves sleep architecture in multiple sclerosis: A prospective polysomnographic study.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Munther QueisiFrom the Department of Neurology, University of Chicago, Chicago, IL (MQ, VPC).
Hrayr AttarianDepartment of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, IL (HA).ORCID https://orcid.org/0000-0002-3983-4323
Veronica P CiprianiFrom the Department of Neurology, University of Chicago, Chicago, IL (MQ, VPC).
Saria AzziMedical Research Volunteer Program, American University of Beirut, Beirut, Lebanon (SA).
Olivia KaczmarekSouth Shore Neurologic Associates, Long Island, NY (OK, BB, MB).
Barbara BumsteadSouth Shore Neurologic Associates, Long Island, NY (OK, BB, MB).
Marijean BuhseSouth Shore Neurologic Associates, Long Island, NY (OK, BB, MB).
Myassar ZarifDepartment of Neurology, NYU Langone Health, New York, NY (MZ, MG).
Daniel GolanDepartment of Neurology, Carmel Medical Center, Haifa, Israel (DG).
Jeffrey WilkenDepartment of Neurology, Georgetown University, Washington DC (JW).
Thomas CoveyDepartment of Neurology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York (TC).
Mark GudesblattDepartment of Neurology, NYU Langone Health, New York, NY (MZ, MG).

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPoor sleep quality and sleep disorders are more prevalent in individuals with multiple sclerosis (MS) than in the general population. Poor sleep has been correlated with worse MS outcomes. Sleep efficiency (SE) is one of the most sensitive markers of sleep quality. There is very little written about SE and other polysomnography (PSG) parameters and MS measures.

methodsThis is a retrospective review of 280 consecutive individuals with MS evaluated by PSGs and other standardized MS measures over 13 years at a comprehensive MS center. In addition, the cohort was assessed with 2 fatigue scales, the Epworth Sleepiness Scale, and the Expanded Disability Status Scale. A comparison of means test (independent

resultsThe PSG measures of SE and Total Sleep Time were significantly different between a group of individuals with MS with a disease duration of more than 5 years vs a group of individuals with MS with a disease duration less than or equal to 5 years. Prevalence of obstructive sleep apnea was 63%, higher than reported in the literature while the prevalence of moderate to severe obstructive sleep apnea was 33.4%, which was lower than reported.

conclusionsLonger disease duration and worse disability correlate with sleep quality as measured by SE.

Indexed as

disease durationEDSSfatiguemultiple sclerosissleep efficiency

Identifiers

PMID38482517
PMCPMC10930806

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.